Belharra Therapeutics is a privately held drug discovery company that is disrupting the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform. Belharra scientists can identify small molecule drug candidates for any binding site, on any protein, in any conformational state, and in any cell type using its chemoproteomicsplatform. Belharra is based in the San Francisco Bay Area, with its primary lab and offices in San Diego.

Biotechnology

Therapeutics

Belharra Therapeutics

Jeff Jonker

Lisa Allen

Olesya Ulanovskaya

Jessica Alexander

Sherry Niessen

Justin Ernst

Sean Buchanan

Sharon Tetlow

Rachel Lane

Gary O’Neill

Research and Development

Leadership Team

Operations

Belharra Therapeutics

Org chart

Teams

Research and Development

Leadership Team

Operations

Similar companies